NURTEC ODT 12 Special Handling Instructions

rimegepant

(

Instructions for handling the medicinal product before administration are:

  • Use dry hands when opening the blister pack.
  • Peel back the foil covering of one blister and gently remove the orally disintegrating tablet. Do not push the tablet through the foil.
  • Take the tablet immediately after opening the blister pack. Do not store the tablet outside the blister pack for future use.

 

Control #: 268384
DEC 1, 2023

)

Find NURTEC ODT medical information:

Find NURTEC ODT medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

NURTEC ODT Quick Finder

Product Monograph
Download Product Monograph

Health Professional Information

12 Special Handling Instructions

Instructions for handling the medicinal product before administration are:

  • Use dry hands when opening the blister pack.
  • Peel back the foil covering of one blister and gently remove the orally disintegrating tablet. Do not push the tablet through the foil.
  • Take the tablet immediately after opening the blister pack. Do not store the tablet outside the blister pack for future use.

 

Control #: 268384
DEC 1, 2023

Resources

Didn’t find what you were looking for? 

Contact us

Call 1-800-463-6001*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

Canada Vigilance Program 

You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect